TNIB ONCOLOGY/INFECTIOUS DISEASE CLINIC NEWZZZ The

New Post Public Reply Private Reply Replies (0) Message Board

Oct 12, 2012 at 9:06 AM

[b]TNIB >> ONCOLOGY/INFECTIOUS DISEASE CLINIC NEWZZZ >The Government [/b]of Malawi & TNI BioTech, Inc. Sign Agreement to Open an Oncology & Infectious Disease Clinic at Queen Elizabeth Central Hospital
Press Release: TNI BioTech, Inc. – Wed, Sep 26, 2012 2:17 PM EDT

President Banda & Dr. Gloria Herndon, President of GBOIG, sign agreement for cancer & infectious disease center. Click here for high-resolution version
NEW YORK, NY--(Marketwire - Sep 26, 2012) - Her Excellency, Mrs. Joyce Banda, the President of the Republic of Malawi, announced today that an agreement has been reached to open an outpatient's clinic at Queen Elizabeth Central Hospital for the treatment of cancer and infectious diseases with US-based biotech firms TNI BioTech, Inc. (TNIB) ( PINKSHEETS : TNIB ) and GB Oncology & Imaging Group LLC (GBOIG).
The World Health Organization estimates that chronic infectious diseases cause more than 20 percent of all cancers in the world, including liver, cervical and gastric malignancies. Infection-related cancers are more frequent and often more severe in people infected with HIV. Cancer patients in Malawi have had abysmal survival rates due to lack of access to early diagnosis and treatment.
President Mrs. Joyce Banda, a long time advocate for women's rights in the areas of health, education and gender equality continues her fight to provide adequate access to effective treatment for cancer and infectious diseases in Malawi; today cancer is almost a death sentence due to a lack of care. President Banda has taken the first step in reversing this problem by signing an agreement with TNIB and GBOIG to open an outpatient clinic for the treatment of cancer, HIV/AIDS and infectious diseases at Queen Elizabeth Central Hospital within the coming months. At the clinic TNIB and GBOIG will deliver both conventional and alternative therapies; including safer, more effective cancer therapies, new-targeted drug therapies and minimally invasive surgical alternatives.
Some of the leaders in the field of immunology and oncology have joined TNIB and GBOIG in their endeavor such as Dr. Ronald Herberman, TNIB's Chief Medical Officer and the founding director of the University of Pittsburgh Cancer Institute (UPCI) as well as the UPMC Cancer Center. Advisory Board Member, Dr. Dalgleish was appointed Foundation Chair of Oncology at St. George's University of London in 1991. Dr. Ndiouga Dieng, a graduate from Howard University, holds the position of Senior Pharmacy Manager at John Hopkins Hospital (Baltimore).
The main objectives of the collaboration between TNIB/GBOIG and Dr. Leo Masamba, one of the only oncologists in Malawi, are to improve access and delivery of clinical care to patients with cancer and infection-related cancers, better understand the link between infectious diseases and cancer, and train the next generation of Malawi-US physicians and scientists to combat infection-associated cancers at home and abroad.
Ultimately, the mandate of the new facility for outpatient cancer care, education and research will allow TNIB/GBOIG to:
Provide first-rate cancer care in Malawi -- a country of about 16 million citizens suffering from one of the highest cancer rates in the world -- in order to improve survival rates for most common cancers under the available therapies from 10 percent to 90 percent, saving an estimated 5,000 lives each year.
Study the interaction between infections and cancer by promoting cutting-edge research aimed at pathophysiology, prevention, diagnosis and treatment of infection-related cancers in Africa.
Improve the quality of medical education in oncology and increase the number of cancer specialists in Malawi.
As part of the agreement, the Government of Malawi has agreed to make space available in the Queen Elizabeth Central Hospital where TNIB/GBOIG will retrofit the facility and start the operation of an outpatient oncology and infectious disease clinic within 6 months; this Phase I will begin in November of 2012 with the aim to have the clinic operational by March of 2013. This clinic will include a CT Scan, an X-Ray Room, a 10 chair infusion chemo-therapy and immune rehabilitating therapy clinic, a sterile room, all related medical supplies, an electronic medical record system and other medical services. In an effort to provide treatment immediately we will initiate the treatment of 10,000 women and children a day for cancer, HIV/AIDS and infectious diseases using IRT-103 LDN, and expand to 250,000-500,000 patients over time. Phase II is focused at adding the necessary Radiation Oncology treatments. The radiation department will be managed by an experienced radiation oncology team and will provide the most advanced technology we can offer aimed at providing the highest chance for healing and recovery; the objective has been set to have Phase II within 12 months.
Dr. Gloria Herndon, President & Managing Member of GBOIG stated "Though cultural change is achieved very slowly, we strongly believe that IRT-103 (LDN) can serve to literally save millions of lives within a relatively short time." "We believe this is an important step forward as there is an urgent need in Malawi for readily available, safe and effective treatments that can hopefully increase the life span and improve the quality of life for millions of cancer and HIV/AIDS infected patients."
"Having a healthy population is essential for the fabric and stability of the nation." "It is imperative to provide care to the people of Malawi in need of care", said President Banda. "It's also the right thing to do." "There can be no greater mandate in cancer treatment and research than to wage the fight by doing the right thing."
Contact:
For more information contact:
Dr. Gloria Herndon
gbherndon@gbiogltd.com
Dr. Ndiouga Dieng
nd@gbiogltd.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Navigating the Maze of Required Minimum Distributions

Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...

Shenzhen's Theme Song Unveils APEC 2026 Vision

A Harmonious Prelude to APEC China 2026 Ever experienced an anthem that captures a city's pulse? That's what Shenzhen's latest creation aims for as it gears up for APEC China 2026. The Publicity Department of the CPC Shenzhen Municipal Committee, alongside Shenzhen Media Group, has crafted something more than just a tune. This is 'Meet You Where Wonders Bloom', a melody...

Abbott's SonicForce Impresses in Crucial Clinical Trial

Breaking Through Cardiac Barriers Never thought I'd see the day when we're literally sending shockwaves through the heart, but here we are. Abbott's makin' waves, quite literally, with its SonicForce™ Coronary Intravascular Lithotripsy (IVL) System. They’ve just dropped some promising 30-day outcomes from the TECTONIC study, which has grabbed the spotlight at the...

Context Labs Unveils AI Distillery for Enterprises

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Naviu's AI Travel Guide: Revolutionizing Japan Tours

A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...

Bass Angler Matt Robertson Reels in Record $1.25M Prize

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

CPC's Rigorous Self-Governance Balances Power Effectively

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...

Dutch Bros Pours Holiday Cheer with New Festive Menu

New Festive Offerings from Dutch Bros Kicking off the holiday season with a splash of vibrant flavors, Dutch Bros is shaking up the menu with some fresh, festive entries. Two new drink concoctions hit the stage alongside a themed delectable treat, and for those traditionalists, perennial favorites make a triumphant return. Dutch Bros Expands Its Vibrant Lineup It's not...

OlloBot's Emotional AI Robots Connect Beyond Tasks

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...